Table 3.
Change in behavior and viral load from study enrollment to 6 month follow-up visit among HIV-infected persons identified through home-based counseling and testing (HBCT)
| N | Baseline^ Median (IQR) | Month 6 Median (IQR) | Change over 6 months | p-value* | |
|---|---|---|---|---|---|
| Behavior and uptake of care | |||||
| Number of sex partners (#2) | 196 | 1.0 (0.0–1.0) | 0.0 (1.0–1.0) | −0.08 | 0.03 |
| N |
Baseline^ N (%) |
Month 6 N (%) |
Change over 6 months | p-value* | |
| Condom use during last sexual intercourse | 186 | 81 (44) | 127 (68) | 25% | <0.001 |
| Clinic visit among HIV+ | |||||
| All | 201 | 115 (57) | 195 (97) | 40% | <0.001 |
| Aware of HIV+ status | 128 | 108 (84) | 125 (98) | 13% | <0.001 |
| Newly identified HIV+ | 73 | 7 (10) | 70 (96) | 86% | <0.001 |
| ART use | |||||
| All participants | 201 | 64 (32) | 99 (49) | 17% | <0.001 |
| Aware of HIV+ status | 128 | 64 (50) | 80 (63) | 13% | <0.001 |
| ART eligible (CD4≤200) | 9 | 3 (33) | 9 (100) | 67% | *** |
| Newly identified HIV+ | 73 | 0 (0) | 19 (26) | 26% | *** |
| ART eligible (CD4≤200) | 9 | 0 (0) | 6 (67) | 67% | *** |
| HIV viral load | Mean HIV viral load (log10 copies/mL) | ||||
| N | Baseline^viral load | Month 6 viral load | Change over 6 months | p-value* | |
| All HIV+ | 196 | 2.92 | 2.64 | −0.28 | 0.02 |
| HIV+ not on ART at baseline | 132 | 3.74 | 3.30 | −0.44 | 0.007 |
| HIV+ on ART at baseline | 64 | 1.24 | 1.30 | 0.06 | 0.624 |
| CD4 ≤200 (excluding HIV+ on ART at baseline) | 12 | 4.93 | 1.70 | −3.23 | <0.001 |
| CD4 201–≤350 (excluding HIV+ on ART at baseline) | 31 | 3.77 | 3.40 | −0.36 | 0.29 |
| Change in percent with viral suppression (<1,000 c/mL) from baseline to 6 months (%) | |||||
| All HIV+ | 196 | 50% | 55% | 5% | 0.21 |
| HIV+ with CD4 ≤200 | 15 | 20% | 80% | 60% | 0.01 |
| HIV+ with CD4 ≤201–≤350 | 47 | 51% | 57% | 6% | 0.55 |
Baseline visit is the first HBCT vist at study enrollment.
McNemar’s test was used to calculate p-value for binary outcome and paired t-test was used to calculate p-value for continuous outcome.
Three participants died and 2 withdrew from the study and were excluded from the follow-up analysis.
Cannot compute McNemar’s p-value due to 0 cell counts (either none on ART at enrollment or none who had not initiated by 6 months).